Antibodies against IL-13 receptor alpha1 and uses thereof

Details Antibodies against IL-13 receptor alpha1 and uses thereof Antibodies against IL-13 receptor alpha1 and uses thereof

2006-01-03

2010-10-05

Skelding, Zachary (Department: 1644)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Structurally-modified antibody, immunoglobulin, or fragment...

C424S143100, C530S387300

Reexamination Certificate

active

07807158

ABSTRACT:
The instant specification discloses an antibody binding to IL-13Rα1, inhibiting IL-13 bioactivity and comprising a variable heavy and a variable light chain, characterized in that the variable heavy chain amino acid sequence CDR3 of this antibody is selected from the group consisting of the heavy chain CDR3 sequences of SEQ ID NO: 1, 3, 5, 7 or 9, and this antibody is useful in the treatment of asthma and allergic diseases.

REFERENCES:
patent: 5770429 (1998-06-01), Lonberg et al.
patent: 5859205 (1999-01-01), Adair et al.
patent: 1 449 851 (2004-08-01), None
patent: WO 97/15663 (1997-05-01), None
patent: WO 03/080675 (2003-10-01), None
patent: WO 2005/019266 (2005-03-01), None
Eduardo Padlan, Mol Immunol. Feb. 1994;31(3):169-217.
Portolano et al., J Immunol. Feb. 1, 1993;150(3):880-7.
Vajdos et al., J Mol Biol. Jul. 5, 2002;320(2):415-28.
Akaiwa, M., et al, “Localization of Human Interleukin 13 Receptor in Non-haematopoietic cells”,Cytokine, 13, (2001) 75-84.
Brüggemann, M., et al., Designer Mice: The Production of Human Antibody Repertoires in Transgenic Animals,Year Immunol., 7 (1993) 33-40.
Fishwild, D.M. et al., High-avidity human IgGK monoclonal antibodies from a novel strain of minilocus transgenic mice,Nat. Biotechnol., 14 (1996) 845-851.
Graber, P., et al., “The distribution of IL-13 receptor α1 expression on B cells, T cells and monocytes and its regulation by IL-13 and IL-4”,Eur. J. Immunol., 28 (1998) 4286-4298.
Jakobovits, A., et al., “Germ-line transmission and expression of a human-derived yeast artificial chromosome”,Nature, 362 (1993) 255-258.
Jakobovits, A., et al., “Analysis of homozygous mutant chimeric mice: Deletion of the immunoglobulin heavy-chain joining region blocks B-cell development and antibody production”,Proc. Natl. Acad. Sci. USA, (1993) 2551-2555.
Poudrier, J., et al., “A soluble Form of IL-13 Receptor α1 Promotes IgG2a and IgG2b Production by Murine Germinal Center B Cells”,J. Immunol., 163 (1999) 1153-1161.
Poudrier, J. et al., “A novel monoclonal antibody, C41, reveals IL-13Rα1 expression by murine germinal center B cells and follicular dendritic cells”,J. Immunol., 30 (2000) 3157-3164.
Van Dijk, .A., et al.,“Human antibodies as next generation therapeutics”, Curr. Opin. Chem. Biol., 5 (2001) 368-374.

Affiliated with

Also associated with

Rating

Antibodies against IL-13 receptor alpha1 and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies against IL-13 receptor alpha1 and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies against IL-13 receptor alpha1 and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4227634